Page last updated: 2024-10-26

etidronate and Hormone-Dependent Neoplasms

etidronate has been researched along with Hormone-Dependent Neoplasms in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
"The primary end point is breast cancer incidence, but major efforts are also being directed at minimizing any fracture risk."5.35IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. ( Cuzick, J, 2008)
"The primary end point is breast cancer incidence, but major efforts are also being directed at minimizing any fracture risk."1.35IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. ( Cuzick, J, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuzick, J1

Other Studies

1 other study available for etidronate and Hormone-Dependent Neoplasms

ArticleYear
IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.
    Expert review of anticancer therapy, 2008, Volume: 8, Issue:9

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms;

2008